Myeloom (MM)

Therapie en prognose

Plasmacel neoplasieen

 


Algemeen
Prognose
Response beoordeling
VTD
MPV
Lenalidomide/Dexamethason
Cyclofosfamide
Lenalidomide
Carfilzomib/Dexamethason
ILD (Ixazomib/Lenalidomide/Dexamethason)
CLD (Carfilzomib/Lenalidomide/Dexamethason)
REP
VCD